(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:732217 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC26A2 mRNA CTD PMID:22079256 1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of SLC26A2 mRNA CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC26A2 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:732217 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of SLC26A2 mRNA more ... CTD PMID:17404688 more ... 17beta-estradiol affects expression ISO RGD:732217 6480464 Estradiol affects the expression of SLC26A2 mRNA CTD PMID:22574217 17beta-estradiol decreases expression ISO RGD:732217 6480464 Estradiol results in decreased expression of SLC26A2 mRNA CTD PMID:19619570 , PMID:21185374 17beta-estradiol increases expression ISO RGD:732217 6480464 Estradiol results in increased expression of SLC26A2 mRNA CTD PMID:16514628 , PMID:31614463 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:732217 6480464 Dihydrotestosterone results in increased expression of SLC26A2 mRNA CTD PMID:29581250 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:732217 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:732217 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of SLC26A2 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:620622 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC26A2 mRNA CTD PMID:32109520 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SLC26A2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:620622 6480464 Tetrachlorodibenzodioxin affects the expression of SLC26A2 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC26A2 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC26A2 mRNA CTD PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:732217 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC26A2 mRNA CTD PMID:19619570 2,4,6-tribromophenol decreases expression ISO RGD:732217 6480464 2 more ... CTD PMID:31675489 2,4,6-trinitrobenzenesulfonic acid decreases expression EXP 6480464 Trinitrobenzenesulfonic Acid results in decreased expression of SLC26A2 mRNA CTD PMID:17982090 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:620622 6480464 3 more ... CTD PMID:23196670 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:732217 6480464 tetrabromobisphenol A results in decreased expression of SLC26A2 protein CTD PMID:31675489 6-propyl-2-thiouracil decreases expression ISO RGD:620622 6480464 Propylthiouracil results in decreased expression of SLC26A2 mRNA CTD PMID:24780913 , PMID:25825206 afimoxifene decreases expression ISO RGD:732217 6480464 afimoxifene results in decreased expression of SLC26A2 mRNA CTD PMID:16514628 afimoxifene multiple interactions ISO RGD:732217 6480464 afimoxifene inhibits the reaction [Estrogens results in increased expression of SLC26A2 mRNA] CTD PMID:21233418 aflatoxin B1 affects expression ISO RGD:732217 6480464 Aflatoxin B1 affects the expression of SLC26A2 protein CTD PMID:20106945 aflatoxin B1 increases expression ISO RGD:732217 6480464 Aflatoxin B1 results in increased expression of SLC26A2 mRNA CTD PMID:32234424 aflatoxin M1 decreases expression ISO RGD:732217 6480464 Aflatoxin M1 results in decreased expression of SLC26A2 mRNA CTD PMID:30928695 all-trans-retinoic acid decreases expression ISO RGD:732217 6480464 Tretinoin results in decreased expression of SLC26A2 mRNA CTD PMID:15498508 , PMID:33167477 ammonium chloride affects expression ISO RGD:620622 6480464 Ammonium Chloride affects the expression of SLC26A2 mRNA CTD PMID:16483693 amphetamine decreases expression ISO RGD:620622 6480464 Amphetamine results in decreased expression of SLC26A2 mRNA CTD PMID:30779732 aristolochic acid A decreases expression ISO RGD:732217 6480464 aristolochic acid I results in decreased expression of SLC26A2 mRNA CTD PMID:33212167 atrazine increases expression ISO RGD:732217 6480464 Atrazine results in increased expression of SLC26A2 mRNA CTD PMID:22378314 benzo[a]pyrene increases methylation ISO RGD:732217 6480464 Benzo(a)pyrene results in increased methylation of SLC26A2 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:732217 6480464 Benzo(a)pyrene results in increased expression of SLC26A2 mRNA CTD PMID:32234424 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:732217 6480464 7 more ... CTD PMID:20018196 bisphenol A decreases expression ISO RGD:620622 6480464 bisphenol A results in decreased expression of SLC26A2 mRNA CTD PMID:25181051 more ... bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SLC26A2 mRNA CTD PMID:34585602 bisphenol A increases methylation ISO RGD:620622 6480464 bisphenol A results in increased methylation of SLC26A2 gene CTD PMID:28505145 cadmium atom increases expression ISO RGD:732217 6480464 Cadmium results in increased expression of SLC26A2 mRNA CTD PMID:24376830 cadmium atom multiple interactions ISO RGD:732217 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC26A2 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:732217 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC26A2 mRNA CTD PMID:35301059 caffeine increases phosphorylation ISO RGD:732217 6480464 Caffeine results in increased phosphorylation of SLC26A2 protein CTD PMID:35688186 CGP 52608 multiple interactions ISO RGD:732217 6480464 CGP 52608 promotes the reaction [RORA protein binds to SLC26A2 gene] CTD PMID:28238834 cisplatin decreases expression ISO RGD:732217 6480464 Cisplatin results in decreased expression of SLC26A2 mRNA CTD PMID:27392435 , PMID:27594783 cobalt dichloride decreases expression ISO RGD:732217 6480464 cobaltous chloride results in decreased expression of SLC26A2 mRNA CTD PMID:19320972 copper(II) sulfate decreases expression ISO RGD:732217 6480464 Copper Sulfate results in decreased expression of SLC26A2 mRNA CTD PMID:19549813 coumarin decreases phosphorylation ISO RGD:732217 6480464 coumarin results in decreased phosphorylation of SLC26A2 protein CTD PMID:35688186 coumestrol multiple interactions ISO RGD:732217 6480464 [Coumestrol co-treated with ESR1 protein] results in increased expression of SLC26A2 mRNA more ... CTD PMID:18310284 , PMID:19167446 cyclosporin A increases expression ISO RGD:732217 6480464 Cyclosporine results in increased expression of SLC26A2 mRNA CTD PMID:20106945 cyclosporin A decreases expression ISO RGD:732217 6480464 Cyclosporine results in decreased expression of SLC26A2 mRNA CTD PMID:25562108 dextran sulfate multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC26A2 mRNA CTD PMID:29950665 dibutyl phthalate decreases expression ISO RGD:620622 6480464 Dibutyl Phthalate results in decreased expression of SLC26A2 mRNA CTD PMID:21266533 dimethylarsinic acid multiple interactions EXP 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC26A2 mRNA CTD PMID:34876320 endosulfan decreases expression ISO RGD:620622 6480464 Endosulfan results in decreased expression of SLC26A2 mRNA CTD PMID:29391264 ethanol increases expression EXP 6480464 Ethanol results in increased expression of SLC26A2 mRNA CTD PMID:30319688 fulvestrant decreases expression ISO RGD:732217 6480464 fulvestrant results in decreased expression of SLC26A2 mRNA CTD PMID:16514628 gentamycin decreases expression ISO RGD:620622 6480464 Gentamicins results in decreased expression of SLC26A2 mRNA CTD PMID:33387578 lidocaine decreases expression ISO RGD:620622 6480464 Lidocaine results in decreased expression of SLC26A2 mRNA CTD PMID:35283115 menadione affects expression ISO RGD:732217 6480464 Vitamin K 3 affects the expression of SLC26A2 mRNA CTD PMID:20044591 methotrexate affects response to substance ISO RGD:732217 6480464 SLC26A2 protein affects the susceptibility to Methotrexate CTD PMID:16217747 methylarsonic acid multiple interactions EXP 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC26A2 mRNA CTD PMID:34876320 nickel dichloride decreases expression ISO RGD:732217 6480464 nickel chloride results in decreased expression of SLC26A2 mRNA CTD PMID:17312168 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of SLC26A2 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:620622 6480464 Acetaminophen results in increased expression of SLC26A2 mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:732217 6480464 Acetaminophen results in increased expression of SLC26A2 mRNA CTD PMID:29067470 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SLC26A2 mRNA CTD PMID:36331819 pirinixic acid multiple interactions ISO RGD:732217 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SLC26A2 mRNA CTD PMID:19710929 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of SLC26A2 mRNA CTD PMID:17426115 potassium chromate decreases expression ISO RGD:732217 6480464 potassium chromate(VI) results in decreased expression of SLC26A2 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:732217 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC26A2 mRNA CTD PMID:22079256 progesterone increases expression ISO RGD:732217 6480464 Progesterone results in increased expression of SLC26A2 mRNA CTD PMID:17404688 progesterone multiple interactions ISO RGD:732217 6480464 [Progesterone co-treated with Estradiol] results in increased expression of SLC26A2 mRNA CTD PMID:17404688 quercetin decreases expression ISO RGD:732217 6480464 Quercetin results in decreased expression of SLC26A2 mRNA CTD PMID:21632981 raloxifene decreases expression ISO RGD:732217 6480464 Raloxifene Hydrochloride results in decreased expression of SLC26A2 mRNA CTD PMID:16514628 resveratrol multiple interactions ISO RGD:732217 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of SLC26A2 mRNA CTD PMID:19167446 rifampicin decreases expression ISO RGD:732217 6480464 Rifampin results in decreased expression of SLC26A2 mRNA CTD PMID:27199754 sodium arsenate multiple interactions EXP 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC26A2 mRNA CTD PMID:34876320 sodium arsenite multiple interactions EXP 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC26A2 mRNA CTD PMID:34876320 sodium fluoride increases expression EXP 6480464 Sodium Fluoride results in increased expression of SLC26A2 protein CTD PMID:28918527 sulforaphane increases expression ISO RGD:732217 6480464 sulforaphane results in increased expression of SLC26A2 mRNA CTD PMID:31838189 tamibarotene affects expression ISO RGD:732217 6480464 tamibarotene affects the expression of SLC26A2 mRNA CTD PMID:15498508 thioacetamide increases expression ISO RGD:620622 6480464 Thioacetamide results in increased expression of SLC26A2 mRNA CTD PMID:34492290 titanium dioxide multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC26A2 mRNA CTD PMID:29950665 trichostatin A increases expression ISO RGD:732217 6480464 trichostatin A results in increased expression of SLC26A2 mRNA CTD PMID:24935251 urethane decreases expression ISO RGD:732217 6480464 Urethane results in decreased expression of SLC26A2 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:732217 6480464 Valproic Acid affects the expression of SLC26A2 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:732217 6480464 Valproic Acid results in increased expression of SLC26A2 mRNA CTD PMID:24935251 vinclozolin increases expression ISO RGD:620622 6480464 vinclozolin results in increased expression of SLC26A2 mRNA CTD PMID:23034163 zidovudine increases expression ISO RGD:732217 6480464 Zidovudine results in increased expression of SLC26A2 mRNA CTD PMID:24292225